Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-01-04
2011-01-04
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S322000, C514S367000, C546S199000, C548S152000, C548S202000, C548S235000, C548S255000, C548S302100, C548S315100, C548S343500, C548S364700, C548S366100, C548S373100, C548S379400
Reexamination Certificate
active
07863310
ABSTRACT:
The present invention provides kinase inhibitors of Formula I:
REFERENCES:
patent: 6040327 (2000-03-01), De Nanteuil et al.
patent: 7320995 (2008-01-01), Bonjouklian et al.
patent: WO-97/25045 (1997-07-01), None
patent: WO-02/072576 (2002-09-01), None
patent: WO-03/042211 (2003-05-01), None
patent: WO-2004/014900 (2004-02-01), None
Bonjouklian et al. “Preparation of benzimi . . . ” CA 140:;199326 (2004).
Zubarovskii et al. “Synthesis of thiazole . . . ” CA 67:116849 (1967).
Gwaltney et al. “Preparation of substituted . . . ” CA 132:137378 (2000).
Prous et al. “Imidazole derivatives . . . ” CA 145:410660(2006).
Bonjouklian et al. “Preparation of benzimidazoles . . . ” CA 140:199326 (2004).
Kai, et al, Preparation of pyrazole derivatives as antiviral agents, Chemical Abstracts, XP002328394, CA125:247806, (1996).
Bonjouklian Rosanne
Dally Robert Dean
de Dios Alfonso
del Prado Catalina Mirian Filadelfa
Dominguez-Fernandez Carmen
Chang Celia
Eli Lilly and Company
Titus Robert D.
Tucker Tina M.
LandOfFree
Kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2629598